Thursday, 30 Jul 2026
  • My Feed
  • My Interests
  • My Saves
  • History
  • Latest Updates
Subscribe
WITHIN NIGERIA
  • HOME
  • NEWS
  • ENTERTAINMENT
  • FACT CHECK
  • 🔥
  • FEATURES
  • POLITICS
  • SPECIAL REPORTS
  • ANALYSIS
  • SPORTS
  • NOLLYWOOD
  • EDUCATION
  • OPINION
  • BUSINESS
  • LIFESTYLE
  • HEALTH
  • TECHNOLOGY
  • PRESS RELEASE
Font ResizerAa
WITHIN NIGERIAWITHIN NIGERIA
  • HOME
  • NEWS
  • ENTERTAINMENT
  • FACT CHECK
Search
Have an existing account? Sign In
Follow US
© WITHIN NIGERIA MEDIA LTD. All Rights Reserved.
National

COVID-19: FG releases N10bn for domestic vaccines production

Last updated: January 18, 2021 9:10 pm
Adejayan Gbenga Gsong
Share
SHARE

The Ministry of Finance has released N10 billion to support domestic vaccines production to tackle COVID-19 pandemic in the country.

The Minister of Health, Dr Osagie Ehanire, made the disclosure at the Presidential Task Force (PTF) COVID-19 briefing on Monday in Abuja.

Ehanire said: “The Ministry of Finance has released N10 billion to support domestic vaccine production.

“While we are working to develop our own vaccines, Nigeria is exploring options for licensed production, in collaboration with recognised institutions. We are also exploring the option of local production of the vaccines in the country.”

He urged Nigerians to ignore claims by some people that they had COVID-19 vaccines for sale in the country.

“I advise all citizens to disregard these claims, as they are criminal. There are procedures for vaccine acquisition and use, which include appropriate regulations and certification by National Agency for Food and Drug and Administration and Control (NAFDAC).

“I advise against fake vaccines, as there is no one approved for use in the country. The National Primary Health Care Development Agency (NPHCDA) is the only authorised vaccine administrator in Nigeria,” he said.

Ehanire stated that the number of new COVID-19 cases had continued to rise in the country, such that 10,300 confirmed cases were reported from just 50,750 samples tested in one week, translating into 20 percent positivity rate.

“It means one out of every five persons tested in the last one week turned out positive, compared with the previous week which recorded a positivity rate of 14 percent.

“Nigeria’s total number of confirmed cases is 110,387 out of a total of 1,172,234 samples tested, with a cumulative positivity rate of 9.4 percent. 1,444 cases were recorded in the past 24 hours, with sadly 77 deaths in the past week and total fatality of 1,435.

“It is instructive of the second wave that all cases recorded so far this January is more than 20 percent of all confirmed cases in Nigeria, more than the whole of December, barely halfway through the month.

“There is no doubting the fact that we are deeply into the second wave of the pandemic which requires that PTF and FMoH review our strategies to respond to the challenge.

“The federal ministry of health has outlined three approaches to confront the pandemic. These are: infection mitigation, therapeutics and vaccines,” he said.

Ehanire reiterated that reducing infection rate for COVID-19 remained the easiest and cheapest objective of the government.

According to him, government’s main effort is to ensure social mobilisation for testing, strengthening surveillance activities for early detection, active contact tracing, isolation and treatment.

He, however, added that implementation of critical non-pharmaceutical measures required the cooperation of the public.

“This includes much more adherence to wearing masks, social distancing, use of sanitiser, etc. than we are seeing today. Of special concern are the so-called “super spreader activities” that involve congregational settings, which must be reduced, restricted or prohibited in the interest of the common good.

“With regards to therapeutics, we must strive to reduce mortality from this disease by ensuring adequate stock of supplies and strengthening our case management capacity.

“In this regard, the ministry of health is working to expand oxygen availability across the country to address shortages, which have been a challenge globally, and also to review the value of various pharmaceuticals and protocols proposed for COVID-19 treatment.

“Clinicians are also urged to work out guidelines for participating in clinical studies,” the minister said.

TAGGED:Covid-19Covid-19 vaccineDr. Osagie EhanireMinistry of Finance
Share This Article
Email Copy Link Print
ByAdejayan Gbenga Gsong
Adejayan is an award-winning Journalist and Opinion writer with varied experience in Nigeria. Mail me at AdejayanOluwagbenga@withinnigeria.com. See full profile on Within Nigeria's TEAM PAGE
Previous Article ” Stay humble” – Bobrisky writes after Iyabo Ojo tackled entitled fans who always ask her for money
Next Article University of Calabar announces resumption date
Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Your Trusted Source for Accurate and Timely Updates!

Our commitment to accuracy, impartiality, and delivering breaking news as it happens has earned us the trust of a vast audience. Stay ahead with real-time updates on the latest events, trends.
FacebookLike
XFollow
InstagramFollow
LinkedInFollow
MediumFollow
QuoraFollow
- Advertisement -
Ad image

You Might Also Like

National

Explosion: Lagos Assembly calls for proper regulation, monitoring of gas sales

By
Adejayan Gbenga Gsong
National

New Minimum Wage: Labour issues December 31 deadline to states

By
Adejayan Gbenga Gsong
Consult native doctors, soothsayers for solution to coronavirus - Monarch tells FG
National

 Monarch tells FG that native doctors, soothsayers needs to be consulted for lasting solution to coronavirus

By
National

Buhari condemns killing of mourners in Borno

By
Adejayan Gbenga Gsong
WITHIN NIGERIA
Facebook Twitter Youtube Rss Medium

About US

 Your instant connection to breaking stories and live updates. Stay informed with our real-time coverage across politics, tech, entertainment, and more. Your reliable source for 24/7 news.

Top Categories
  • World News
  • Opinion
  • Politics
  • Tech
  • Health
  • Travel
Usefull Links
  • Contact Us
  • Advertise with US
  • Complaint
  • Privacy Policy
  • Cookie Policy

© . All Rights Reserved.